Wu v. AstraZeneca Separation Plan et al
| Dedong Wu |
| AstraZeneca Separation Plan and AstraZeneca Administration Committee |
| 1:2026cv01280 |
| October 5, 2026 |
| U.S. District Court for the District of Delaware |
| Labor: E.R.I.S.A. |
| 29 U.S.C. ยง 1132 E.R.I.S.A.-Employee Benefits |
| None |
Docket Report
This docket was last retrieved on October 6, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 Summons Issued as to AstraZeneca Administration Committee on 10/6/2026. (scs) |
| Remark: MAG Packet, Rule 4 Packet, Issued Summons and Pro-Se Privacy Notice mailed to plaintiff. (scs) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) |
| Filing 1 COMPLAINT filed Pro Se against AstraZeneca Administration Committee, AstraZeneca Separation Plan (Filing fee $ 405, receipt number 6024) - filed by Dedong Wu. (Attachments: #1 Exhibits, #2 Civil Cover Sheet, #3 Envelope)(scs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.